Condensed Consolidated Statements of Changes in Convertible Preferred Stock, Stockholders’ Equity and Non-Controlling Interest - USD ($) $ in Thousands		Total		Additional Paid-In Capital	Accumulated Deficit	Non- Controlling Interests	Common Stock Class A	Common Stock Class A Common Stock	Common Stock Class F Common Stock	Common Stock Class B	Common Stock Class B Common Stock
Balance as of beginning of period (in shares) at Dec. 31, 2024		11,865,046
Balance as of beginning of period at Dec. 31, 2024		$ 25,018
Balance as of end of period (in shares) at Mar. 31, 2025		11,865,046
Balance as of end of period at Mar. 31, 2025		$ 25,018
Common stock, beginning balance (in shares) at Dec. 31, 2024								2,455,894	10,000,000		20,075,183
Beginning balance at Dec. 31, 2024		42,595		$ 200,811	$ (169,846)	$ 11,627		$ 0	$ 1		$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B Common Stock (in shares)											60,596
Issuance of Class B Common Stock		963		963
Redemption of Class B Common Stock (in shares)											(202,653)
Redemption of Class B Common Stock		(2,174)		(2,174)
Offering costs for Class B Common Stock		(21)		(21)
Exercise of Common A RSOs (in shares)								2,500
Exercise of Common A RSOs		13		13
Distribution of Member’s Equity of NCI		(53)				(53)
Net loss		(4,241)			(4,403)	162
Common stock, ending balance (in shares) at Mar. 31, 2025								2,458,394	10,000,000		19,933,126
Ending balance at Mar. 31, 2025		$ 37,082		199,592	(174,249)	11,736		$ 0	$ 1		$ 2
Balance as of beginning of period (in shares) at Dec. 31, 2025		11,865,046
Balance as of beginning of period at Dec. 31, 2025	[1]	$ 25,018
Balance as of end of period (in shares) at Mar. 31, 2026		11,865,046
Balance as of end of period at Mar. 31, 2026		$ 25,018
Common stock, beginning balance (in shares) at Dec. 31, 2025							2,458,394	2,458,394	10,000,000	19,826,469	19,826,469
Beginning balance at Dec. 31, 2025		30,548	[1]	200,586	(182,298)	12,257		$ 0	$ 1		$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification of Accumulated Deficit to NCI		0			(1,332)	1,332
Issuance of Class B Common Stock (in shares)											236,326
Issuance of Class B Common Stock		3,758		3,758
Redemption of Class B Common Stock (in shares)											(6,206)
Redemption of Class B Common Stock		(73)		(73)
Offering costs for Class B Common Stock		(23)		(23)
Distribution of Member’s Equity of NCI		(2,450)				(2,450)
Net loss		(3,955)			(4,084)	129
Common stock, ending balance (in shares) at Mar. 31, 2026							2,458,394	2,458,394	10,000,000	20,056,589	20,056,589
Ending balance at Mar. 31, 2026		$ 27,805		$ 204,248	$ (187,714)	$ 11,268		$ 0	$ 1		$ 2

[1] Derived from audited financials